跳至主要内容
临床试验/CTRI/2025/11/096836
CTRI/2025/11/096836尚未招募2/3 期

Effectiveness of Triphala Ghrita Nasya along with Antioxidant Therapy and Antioxidant Therapy alone in the management of Vataja Timira with Reference to Age Related Macular Degeneration (Dry type)- A Randomized Controlled Clinical Trial.

Dr Rutika Sainath Hamare1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2026年1月1日最近更新:

试验速览

阶段
2/3 期
状态
尚未招募
发起方
入组人数
60
试验地点
1
主要终点
Triphala Ghrita Nasya and Antioxidant Therapy is significantly effective than Antioxidant Therapy only in symptoms of Vataj Timir with reference to Age Related Macular Degneration (Dry Type)

研究概览

简要总结

this is randomized controlled clinical trial assessing the effectiveness of Triphala Ghrit Nasya and Antioxidant with Antioxidant therapy only given for 21 days in 60 patients will be observed for 42 days. the primary outcome is to see effect of treatment on Vataja Timira (ARMD)symptoms .secondary outcome is to see on visual acuity , amsler grid, peli robson chart contrast sensitivity chart .

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
50.00 Year(s) 至 65.00 Year(s)(—)
性别
All

入选标准

  • patient with distant vision less than equal to 6/9 with symptoms like bhramativa darshana (objects seems to be moving) avila darshana (blur vision) arunah darshana (slight red) vyavidha darshana (metamorphopsia).

排除标准

  • 1.retinal diseases except ARMD dry type 2.systemic diseases which affect macula like uncontrolled DM , hypertention.
  • 3.cataract patients 4.patients contraindicated for nasya.

结局指标

主要结局

Triphala Ghrita Nasya and Antioxidant Therapy is significantly effective than Antioxidant Therapy only in symptoms of Vataj Timir with reference to Age Related Macular Degneration (Dry Type)

时间窗: 0th,7th,14th,21st,28th and 42nd day.

次要结局

  • Triphala Ghrita Nasya and Antioxidant Therapy is not significantly effective than Antioxidant Therapy only in symptoms of Vataj Timir with reference to Age Related Macular Degneration (Dry Type)(0th,7th,14th,21st,28th and 42nd day.)

研究者

发起方
Dr Rutika Sainath Hamare
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Rutika Sainath Hamare

Dr.G.D.Pol Foundation ,YMT Ayurvedic Medical College and Hospital

研究点 (1)

Loading locations...

相似试验